HomeInsightsPE

Cipla Ltd PE Ratio

Cipla Ltd PE Ratio

stocks purchased

₹ 10.6 Cr

Volume Transacted

(Dec 12, 2024)

stocks purchased

73.6 K

Stocks Traded

(Dec 12, 2024)

Last Updated on: Dec 12, 2024

Image

Cipla Ltd

NSE: CIPLA

PE

25.4

Last updated on: Dec 12, 2024

Key Highlights

  • The P/E Ratio of Cipla Ltd is 25.4 as of 12 Dec 15:30 PM .
  • The P/E Ratio of Cipla Ltd changed from 27.9 on March 2019 to 29.3 on March 2024 . This represents a CAGR of 0.82% over 6 years.
  • The Latest Trading Price of Cipla Ltd is ₹ 1446 as of 12 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Cipla Ltd

No data available

Company Fundamentals for Cipla Ltd

No data available

Image

Cipla Ltd

NSE: CIPLA

Share Price

₹ 1446.35

-7.85 (-0.54%)

stock direction

Last updated on: Dec 12, 2024

Market Price of Cipla Ltd

1M

1Y

3Y

5Y

Monitoring Cipla Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 20241454.2
10 Dec 20241455.65
09 Dec 20241469.3
06 Dec 20241477.6
05 Dec 20241498.9
04 Dec 20241501.1
03 Dec 20241534.4
02 Dec 20241508.1
29 Nov 20241534.4
28 Nov 20241492.85

SWOT Analysis Of Cipla Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Cipla Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Cipla Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Cipla Ltd251,17,443
Sun Pharmaceuticals Industries Ltd384,35,407
Divis Laboratories Ltd851,57,489
Torrent Pharmaceuticals Ltd651,14,197
Mankind Pharma Ltd491,05,098
Dr Reddys Laboratories Ltd191,03,338

Key Valuation Metric of Cipla Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Cipla Ltd

No data available

* All values are in crore

Historical Revenue of Cipla Ltd

No data available

* All values are in crore

Historical EBITDA of Cipla Ltd

No data available

* All values are in crore

Historical Net Profit of Cipla Ltd

No data available

* All values are in crore

Historical Dividend Payout of Cipla Ltd

No data available

* All values are in %

About Cipla Ltd

  • Cipla Ltd is one of the leading pharmaceutical companies in India.
  • The Company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).
  • Cipla's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments.
  • With a rich portfolio, it is deepening presence in the home markets of India, as well as South Africa, North America, and other key regulated and emerging markets.
  • Its 47 manufacturing sites around the world produce more than 50 dosage forms and over 1,500 products across wide range of therapeutic categories. Cipla Ltd was incorporated in the year 1935 with the name Chemical, Industrial & Pharmaceutical Laboratories Ltd.

Cipla Ltd News Hub

News

Cipla Ltd up for five straight sessions

Cipla Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 1586.85,...

Read more

2024-08-12 00:00:00

News

Cipla Ltd gains for third straight session

Cipla Ltd is up for a third straight session today. The stock is quoting at Rs 1574.65, up...

Read more

2024-08-08 00:00:00

News

Cipla allots 6,815 equity shares under ESOS

Cipla has allotted 6,815 equity shares under Employee Stock Option Scheme on 02 August 202...

Read more

2024-08-02 00:00:00

News

Cipla announces board meeting date

Cipla will hold a meeting of the Board of Directors of the Company on 3 September 2024. Po...

Read more

2024-09-04 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Cipla Ltd

What is the current PE Ratio of Cipla Ltd?

The Current PE Ratio of Cipla Ltd is 25.44 as on 12 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Dec 2024.

What was the PE Ratio of Cipla Ltd last year?

The PE Ratio of Cipla Ltd was 25.95 last year, now the PE ratio is 25.44, showing a year-on-year growth of -2.0%.

What does the PE Ratio of Cipla Ltd indicate about its stock?

The PE Ratio of Cipla Ltd is 25.44. This ratio indicates that investors are willing to pay 25.44 times the earnings per share for each share of Cipla Ltd.

What is the PE Ratio Growth of Cipla Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Cipla Ltd grew by -2.0% whereas, the EPS ratio grew by 10.6.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions